G Coghlan
Overview
Explore the profile of G Coghlan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma V, Al Saikhan L, Park C, Hughes A, Gu H, Saeed S, et al.
Echo Res Pract
. 2020 Oct;
7(4):M1.
PMID: 33112840
No abstract available.
2.
Houston B, Zelinski T, Israels S, Coghlan G, Chodirker B, Gallagher P, et al.
Blood Cells Mol Dis
. 2011 Sep;
47(4):226-31.
PMID: 21944700
The hereditary stomatocytoses are a group of heterogeneous conditions associated with chronic red cell hemolysis for which the causative genetic mutations are not known. We investigated 137 members of a...
3.
Vachiery J, Coghlan G
Eur Respir Rev
. 2010 Oct;
18(113):162-9.
PMID: 20956137
The onset and progression of pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc) can be particularly aggressive; however, effective treatments are available. Therefore, early identification of patients with...
4.
Kahan A, Coghlan G, McLaughlin V
Rheumatology (Oxford)
. 2009 Jun;
48 Suppl 3:iii45-8.
PMID: 19487224
The majority of patients with SSc are believed to have subclinical primary cardiac involvement. Overt cardiac manifestations of SSc are associated with poor prognosis and can be difficult to manage....
5.
McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V
Rheumatology (Oxford)
. 2009 Jun;
48 Suppl 3:iii25-31.
PMID: 19487219
Pulmonary arterial hypertension (PAH) is a devastating vascular complication of a number of CTDs. In patients with SSc, PAH has a dramatic impact on prognosis and survival and is the...
6.
Hughes D, Elliott P, Shah J, Zuckerman J, Coghlan G, Brookes J, et al.
Heart
. 2007 May;
94(2):153-8.
PMID: 17483124
Background: Anderson-Fabry disease is an X-linked glycosphingolipid storage disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. This leads to a progressive accumulation of globotriaosylceramide (Gb(3)) in the...
7.
Zelinski T, Coghlan G, Mauthe J, Triggs-Raine B
Mol Genet Metab
. 2006 Dec;
90(2):210-6.
PMID: 17166756
The tetrameric glycoprotein butyrylcholinesterase (BChE; EC 3.1.1.8) is one of two enzymes that hydrolyze choline esters. The controlling gene (BCHE) is comprised of four coding exons and is located on...
8.
Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M, et al.
Bone Marrow Transplant
. 2004 Nov;
34(10):877-81.
PMID: 15517007
Autologous haematopoietic stem cell transplantation is now a feasible and effective treatment for selected patients with severe autoimmune diseases. Worldwide, over 650 patients have been transplanted in the context of...
9.
Green C, Coghlan G, BIZOT M, Kasulke D, Wallace M, Lomas-Francis C, et al.
Transfus Med
. 2002 Apr;
12(1):55-61.
PMID: 11967138
We have investigated a 'new' low frequency antigen JAHK, which is a marker for the rare Rh gene complex rG. The rG haplotype does not produce any D, c or...
10.
Zelinski T, RUSNAK A, McManus K, Coghlan G
Vox Sang
. 2001 Jan;
79(4):215-8.
PMID: 11155072
Background And Objectives: Phenotypically, Sw(a+) erythrocytes have been classified as either 700:4,41 or 700:4,-41. Since anti-700.4, in particular, and sometimes anti-700.41 are contained in reagents defining other low-incidence antigens that...